Efficiencies and Complications of Dual Chamber versus Single Chamber Implantable Cardioverter Defibrillators in Secondary Sudden Cardiac Death Prevention: A Meta-analysis-Reference-Cited by-同舟云学术

Efficiencies and Complications of Dual Chamber versus Single Chamber Implantable Cardioverter Defibrillators in Secondary Sudden Cardiac Death Prevention: A Meta-analysis

Published:2016-02 Issue:2 Volume:25 Page:148-154
ISSN:1443-9506
Container-title:Heart, Lung and Circulation
language:en
Short-container-title:Heart, Lung and Circulation

Author:

Hu Zuo-Ying,Zhang Juan,Xu Zhou-Tao,Gao Xiao-Fei,Zhang Hang,Pan Chang,Chen Shao-Liang

Publisher

Elsevier BV

Reference25 articles.

1. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators;Moss;N Engl J Med,1996

2. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction;Moss;N Engl J Med,2002

3. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure;Bardy;N Engl J Med,2005

4. Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry;Matlock;Arch Intern Med,2012

5. Importance of the atrial channel for ventricular arrhythmia therapy in the dual chamber implantable cardioverter defibrillator;Dijkman;J Cardiovasc Electrophysiol,2000

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Single- vs. Dual-Lead CIEDs Regarding Perioperative Complications-Analysis of the Quality Assurance Data of the State of North Rhine-Westphalia, Germany;Journal of Clinical Medicine;2025-05-06

2. ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing;Journal of the American College of Cardiology;2025-03

3. 2024 HRS expert consensus statement on arrhythmias in the athlete: Evaluation, treatment, and return to play;Heart Rhythm;2024-10

4. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines;Circulation;2024-06-04

5. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy;Journal of the American College of Cardiology;2024-06